CANCER-ASSOCIATED MACROPHAGELIKE (CAML) CELLS TO ENHANCE DETECTION OF EARLY-STAGE LUNG CANCER AND RELAPSE AFTER DEFINITIVE TREATMENT
$672,969FY2018Department of the ArmyDOD
The Institute For Cancer Research
Investigators
View source on USAspending →CANCER-ASSOCIATED MACROPHAGELIKE (CAML) CELLS TO ENHANCE DETECTION OF EARLY-STAGE LUNG CANCER AND RELAPSE AFTER DEFINITIVE TREATMENT · GrantIndex